Equity
€32,973 from €75,831 in 2018
Equity fell by 57% in 7 years.
Dr. Johan Janssens
Lifetime
12 annual accounts with figures on one time axispeak €153,610 (2025)
€153,610▲ 22.5%
peak €119,940 (2024)
€117,606▼ 1.9%
peak €75,831 (2018)
€32,973▼ 41.5%
€179,675▲ 26.9%
Board1 name since 2021
1 directorJANSSENS Johan Antoine Lutgart Jacques
Documentsfilings and deeds
13-08-202613 days late
2025micro format
Gross margin from €125,395 to €153,610Dividend €141,000Equity from €56,367 to €32,973Debts from €141,538 to €179,675
Key points
from the 2025 annual accountsChecked score
92
Excellent
Financially stronger than 35% of micro companies in human health (NACE 86)
Probability in this band: under 0.55%
Bankruptcy probability within 12 months
< 0.1% Very low
0%0.5%1.5%4%10%≥ 25%
The dashed line is the sector median: < 0.1% across 24,179 companies (NACE 86, micro).
Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).
Last 24 months
12-2024: < 0.1%lowest value
01-2025: < 0.1%● unchanged vs 12-2024lowest value
02-2025: < 0.1%● unchanged vs 01-2025lowest value
03-2025: < 0.1%● unchanged vs 02-2025
04-2025: < 0.1%● unchanged vs 03-2025
05-2025: < 0.1%● unchanged vs 04-2025
06-2025: < 0.1%● unchanged vs 05-2025
07-2025: < 0.1%● unchanged vs 06-2025
08-2025: 0.1%▲ +0.1 percentage points vs 07-2025
09-2025: < 0.1%▼ -0.1 percentage points vs 08-2025
10-2025: < 0.1%● unchanged vs 09-2025
11-2025: < 0.1%● unchanged vs 10-2025
12-2025: < 0.1%● unchanged vs 11-2025
01-2026: < 0.1%● unchanged vs 12-2025
02-2026: < 0.1%● unchanged vs 01-2026
03-2026: < 0.1%● unchanged vs 02-2026
04-2026: < 0.1%● unchanged vs 03-2026
05-2026: < 0.1%● unchanged vs 04-2026
06-2026: < 0.1%● unchanged vs 05-2026
07-2026: < 0.1%● unchanged vs 06-2026
08-2026: 0.1%▲ +0.1 percentage points vs 07-2026highest value
09-2026: < 0.1%▼ -0.1 percentage points vs 08-2026
10-2026: < 0.1%● unchanged vs 09-2026
11-2026: < 0.1%● unchanged vs 10-2026
Financial strengthStrong
Score breakdown
lowers risk
Sector: Human health activities (NACE 86)
Size: total assets €212,647
Liquidity: current ratio 0.86, cash €90,936
Figures for financial year 2025 (filed on 13-08-2026)
Calculation
The band follows from the bankruptcy probability. 10 more points roughly halve it.
| 75-100 | Excellent | under 0.55% |
| 60-74 | Healthy | 0.55% to 1.5% |
| 45-59 | Fair | 1.5% to 4.2% |
| 25-44 | Weak | 4.2% to 15.0% |
| 0-24 | Critical | over 15.0% |
Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, micro). It does better than 17% of them on solvency, 28% on liquidity, 80% on profitability and 14% on growth.
The bankruptcy probability was computed on 05-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.
The probability rests on the annual accounts with balance sheet date 31-12-2025.
Of the companies with a bankruptcy probability in the very low class on 30-06-2025, 0.1% went bankrupt within twelve months.
Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).
Comparable companies, two years later
In July 2024, 5,053 companies had the same profile as Dr. Johan Janssens has now. Each dot stands for 13 companies, two years later.
95.9%
were still trading
2.4%
stopped another way
1.6%
went bankrupt
Another 0.1% stopped without a precise date, possibly only after those two years.
The bankruptcy probability of Dr. Johan Janssens itself is lower: < 0.1% within 12 months. It rests on far more data about Dr. Johan Janssens than the profile alone.
Test of the method
The method was tested on the 497,447 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 0.9% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.8% |
| 9 | 3.0% | 3.1% |
| 10 | 5.6% | 6.2% |
A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.
This is an observation about 5,053 companies, not a prediction for Dr. Johan Janssens. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.
Credit verdict
Credit of up to €3,000 on 30-day terms is acceptable
Liquidity is insufficient, with a current ratio of 0.86 (0.96 in 2024), below 1. Short-term debt is 84.5% and cash 42.8% of total assets. 84.5% of the assets are financed with debt and provisions.
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
Six signals.
lowers riskraises risk
raises risk · Weak solvency compared with the sector
Solvency (equity / total assets) is in the sector's weakest quartile: better than 17% of 20749 sector peers (2025).
NBB · sector comparisonPosition among 20749 sector peers
Solvency
better than 17%
← weakest
strongest →
raises risk · 2025 accounts filed 13 days late
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 13-08-2026, 13 days later. Nearly half (47%) of Belgian companies file late; of those that file 1 to 90 days late, 2.0% are now bankrupt, dissolved or in another special legal status, against 1.66% of all filers. A delay like this does not count in the score.
NBB · 10 filingsDeviation from the deadline
2025
13 days late
2024
22 days late
2023
21 days late
2022
28 days late
2021
8 days early
2020
26 days early
2019
30 days early
← before the deadline
after the deadline →
tick = median of all Belgian filingsring = median in the sector
The company filed its last 7 accounts on average 3 days after the deadline. In the sector (NACE 86), the median for financial year 2024 was 7 days before the deadline, and 36% of those companies filed late.
Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 22 August (5 of the last 5 accounts filed within 30 days either side of that date).
Companies Code · seven monthsWhere today falls in the filing period
06-11-2026 today31-12-2026 year end31-07-2027 deadline
Recent changes
Registered in the Peppol Directory
Reachable for e-invoices through 0208:0536484531
Change of role: JANSSENS Johan Antoine Lutgart Jacques, from manager to director
Director discharge: JANSSENS Johan Antoine Lutgart Jacques · General meeting of 18-10-2023 · Gazette deed
Incorporation
published on 17-07-2013 · Gazette deed
First establishment
Leugstraat 167, Aartselaar
Comparable companies
same main activity, similar in size and age| Company | ||||
|---|---|---|---|---|
| Dr. Johan Janssens Aartselaar | €212,647 | €153,610 | 15.5% | - |
| MEDISCH KABINET DR. VAN DAM JAN, HUISARTS Steenokkerzeel | €217,838 | €152,096 | 23.2% | - |
| DR COUSSEMENT BERNARD Roeselare | €196,334 | €156,013 | 10.8% | - |
| Docteur de Marneffe Philippe Huy | €228,264 | €165,633 | 9.0% | - |
| WOLUMED Woluwe-Saint-Pierre | €219,972 | €167,236 | 8.5% | - |
| Centre Médical du Gris Moulin La Hulpe | €214,061 | €146,193 | 61.7% | - |
| DR. KOEN VENUS, HUISARTS Duffel | €251,985 | €141,788 | 12.2% | - |
These companies have the same main activity as Dr. Johan Janssens: general medical practice (NACE 86210). They are comparable in size and age: total assets between €196,000 and €252,000, founded between 2010 and 2016.
Official details
Source: KBO- Status
- Active since 01-07-2013Normal situation
- Activity
- General medical practiceNACE 86210
- Establishment unit
- 2.221.720.9592630 Aartselaar, since 01-07-2013
- Financial year end
- 31 December
- Peppol
- Reachable since 23-12-2025
Annual accounts 2025
- ≈ €290,000estimated
- €212,647▲ 7.4%
- ≈ 0 FTEestimated
- Filing
- Filed on 13-08-2026
Insights on Dr. Johan Janssens
Dr. Johan Janssens files the micro format. That format states no turnover. The gross margin rose from €71,732 in 2014 to €153,610 in 2025.
Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.
Key facts about Dr. Johan Janssens
- What is the company number of Dr. Johan Janssens?
- The company number of Dr. Johan Janssens is 0536.484.531. The VAT number is the same number with BE in front: BE 0536.484.531.
- Where is Dr. Johan Janssens based?
- The registered office is at Leugstraat 167, 2630 Aartselaar.Company details
- What does Dr. Johan Janssens do?
- According to the KBO register, the main activity is general medical practice (NACE 86210).
- What is the legal form of Dr. Johan Janssens?
- Dr. Johan Janssens is a private limited company (BV).
- When was Dr. Johan Janssens founded?
- Dr. Johan Janssens was founded on 01-07-2013.
- Is Dr. Johan Janssens still active?
- Yes, Dr. Johan Janssens is an active enterprise in the KBO register.
- What is the turnover of Dr. Johan Janssens?
- The turnover in financial year 2025 is ≈ €290,000. This figure is estimated from the gross margin of €153,610 and 30 comparable companies (NACE 86210). It probably lies between €220,000 and €350,000.Financials
- Is Dr. Johan Janssens profitable?
- In financial year 2025, Dr. Johan Janssens made a profit of €117,606.
- Where can I find the annual accounts of Dr. Johan Janssens?
- Dr. Johan Janssens filed 12 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
- When are the next annual accounts of Dr. Johan Janssens due?
- Dr. Johan Janssens must file the annual accounts for financial year 2026 by 31-07-2027.Timeline
Next steps
Work out how much credit to give this customer and on what payment terms.Credit check Check what to know before you do business with this company.Supplier due diligence Check whether you can accept this company as a client under the anti-money-laundering law.AML client file Check which of your other customers you can e-invoice via Peppol.Peppol check Compare this company with its sector.Sector benchmark See what changed in the latest annual accounts.What changed
See how customers, suppliers and banks see your own company and what to improve first.